Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here



Monday Morning Coffee with TradingMarkets

By David Penn | TradingMarkets.com
Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS
Good Morning!

"No Country for Old Men" Wins Four Oscars... Electronic Arts Bids on Take-Two... Genentech Up Big in Pre-Market with Avastin News... VISA IPO Could Be Largest Ever in U.S.... Tiger Woods Wins Match Play Final... Lowe's Earning Beat Estimates, Guidance Disappoints... Ambac Up On Capital Infusion Rescue Rumors... Economists Insist Recession Likely in 2008.

Asian stocks up... European stocks up... Greenbacks moving higher against the yen... And the futures are trending lower in the hour before the bell.

Take the TradingMarkets Path to Professional Trading - Level 1 course and immediately improve your trading. It's free! Start here.

TradingMarkets 5 Business Stories You Need to Know

Electronic Arts Bids for Take-Two - Wall Street Journal
Electronics Arts $2 billion offer for Take-Two Interactive is the latest unsolicited bid in the world of technology. EA has bid $26 per share for the company, which has rejected the bid. EA's offer represents a 64% premium on the shares as of the February 15 close, and the company has said it will take its offer directly to shareholders.

Lowe's Beats, But Guidance Soft - Bloomberg
Weakness in the housing markets continues to impact revenues and earnings at Lowe's, one of the leading home improvement retailers. Earnings fell less than analyst projected, with Lowe's buoyed by price cuts and superior customer satisfaction compared to rival, Home Depot.

Do or Die Dollar? - DailyFX
Chief currency strategist Kathy Lien takes a look at the U.S. economy as a way of figuring out the dollar's next move. Will continued fears of economic weakness in the U.S. continue to drag the dollar lower? Or will the idea of a world-wide slowdown in growth actually help the U.S. dollar against other curencies?

Genentech's Avastin Wins Approval - TheStreet
Genentech, the largest producer of anti-cancer medicines in the United States, announced that it had won approval to market its breast cancer treatment, Avastin. The new drug could result in sales of more than $700 million in 2008.

VISA IPO May Be Biggest Ever - Wall Street Journal
If VISA goes through with its planned initial public offering, the sale of more than $17 billion in stock would make the IPO the largest ever in U.S. history. The company plans to sell 406 million shares priced between $37 and $42 each. In 2006, VISA completed nearly twice as many transactions as rival Mastercard.

For more stories as they happen, go to our Breaking News section.

TradingMarkets 7 Stocks You Need to Know for Today

Here are 7 stocks for traders for today from TradingMarkets.com:

For a list of today’s highest PowerRating stocks, click here.

TradingMarkets 5 Top PowerRatings Stocks for Today

Company
Symbol PowerRatings
Zoltek ZOLT 8
Spire SPIR 8
Sonus Networks SONS 8
Janus Capital JNS 8
PNM Resources PNM 8
» View More Stocks

TradingMarkets Tracking the Wizards

UBS Magnus Warns of More Trouble to Come - Financial Times
Senior economic advisor for UBS, George Magnus sits down with the Financial Times for this three-part discussion of the possibility of a trillion dollar meltdown" as well as his contention that economic conditions will deteriorate to the point of the United States needing to create a bailout package for the financial sector by October.

A Goldman Stumble in March? - Wall Street Journal
Could Goldman Sachs incredible record of 10 consecutive quarters of ever higher year-over-year earnings per share finally come to an end?

Market Testing Wizards to the Rescue! - TradingMarkets
Got a trading plan? If so, are you serious enough about your success to have your trading strategy backtested by a team of market professionals? Click here for your free report on the "10 Steps to Successful Backtesting," from Market Testing Wizards. Whether or not you are new to backtesting or an old hand at analyzing parameters and optimizing performance, Market Testing Wizards will let you know if your trading plan is truly a winning one.

View Portfolios of Prominent Investors

TradingMarkets Playbook

The rally late in the day on Friday helped the market carve out a potential higher low vis-a-vis the lows from earlier in the month. Again, what is key is follow-through after the market managed to close nearer its highs on the last trading day of the week.

We are seeing a less severe ratio of overbought to oversold stocks in our TradingMarkets Stock Indicators this morning comapred to previous mornings, which suggests that the market will have room to move still higher before becoming dangerously overbought. The number of bargains for traders looking to the long side is not great. But the number of those stocks seems to have increased from last week.

It is worth noting that there has been a bullish tendency to the end of the month, as we have documented in our research at TradingMarkets. While this alone is no reason to become wildly bullish, it may be a reason--combined with other factors--for traders to forego aggressive shorting for the time being.

David Penn is Senior Editor at TradingMarkets.com.

Click here to sign up for the Morning Coffee with TradingMarkets newsletter.


>> See more articles by David Penn
Stocks RSS
Related Articles
More Related Articles >>
PREMIER SPONSORED LINKS
TRADE CENTER
 
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.